Extending combination therapy with peginterferon alfa-2b plus ribavirin for genotype 1 chronic hepatitis C late responders: a report of 9 cases

Hepatology. 2003 May;37(5):1226-7. doi: 10.1053/jhep.2003.50107.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Antiviral Agents / administration & dosage*
  • Drug Therapy, Combination
  • Female
  • Genotype
  • Hepacivirus / genetics*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha* / administration & dosage*
  • Male
  • Middle Aged
  • Polyethylene Glycols*
  • Recombinant Proteins
  • Ribavirin / administration & dosage*

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2b
  • peginterferon alfa-2a